MELD/MELDNa scores

The Model for End-Stage Liver Disease (MELD) stratifies patients according to the severity of their liver disease. It is also useful in predicting mortality after transjugular intrahepatic portosystemic shunt (TIPS), cirrhotic patients undergoing non-transplantation surgical procedures, acute alcoholic hepatitis, and acute variceal hemorrhage.

The MELD score has been widely validated in several studies and has been well accepted by the United Network for Organ Sharing (UNOS) for the prioritization of patients awaiting liver transplantation in the United States.